1134 — Kelfred Holdings Income Statement
0.000.00%
HealthcareHighly SpeculativeMicro CapFalling Star
- HK$315.00m
- HK$270.61m
- HK$465.43m
Annual income statement for Kelfred Holdings, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 421 | 413 | 354 | 435 | 465 |
Cost of Revenue | |||||
Gross Profit | 96.7 | 96.3 | 60.1 | 68.4 | 76 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 381 | 398 | 366 | 436 | 454 |
Operating Profit | 40.4 | 15.6 | -11.6 | -1.1 | 11.4 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 38.4 | 13.7 | -12.2 | -1.59 | 10.7 |
Provision for Income Taxes | |||||
Net Income After Taxes | 31 | 9.1 | -13.5 | -2.14 | 9.18 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 30.4 | 8.38 | -13.4 | -2.14 | 9.18 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 30.4 | 8.38 | -13.4 | -2.14 | 9.18 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.098 | 0.04 | -0.027 | -0.004 | 0.018 |
Dividends per Share |